Top Stories Friday, November 18, 2016 Spectrum has said in a SEC filing that the U.S. regulator has rejected its application for Qapzola (apaziquone) for bladder cancer. Friday, November 18, 2016 Clovis Oncology is facing a lawsuit over statements about the safety and efficacy of its now-scrapped lung cancer candidate rociletinib. The lawsuit stems from questions about the timing and truthfulness of statements Clovis made about rociletinib results as it raced against AstraZeneca to bring an EGFR inhibitor to market. Robbins Arroyo is behind the lawsuit. Friday, November 18, 2016 Motif Bio has put together a financing package to give it the money to wrap up a Phase III trial of its antibiotic iclaprim. The agreement will see Motif Bio list on Nasdaq at the second attempt if it can sell at least 20 million shares through a placement in Europe. Friday, November 18, 2016 Micro cap Neurotrope has raised $20 million in a private placing as it looks to push on with its drug development programs and potentially list on the Nasdaq. Thursday, November 17, 2016 Seventh Sense Biosystems picked up a $10 million Series C to develop new products around and to expand manufacturing capacity for its “push-button” blood collection device. Thursday, November 17, 2016 In this week's EuroBiotech Report, Witty warns of EMA disruption, Bristol-Myers inks microbiome pact, Erytech pulls filing and more. Thursday, November 17, 2016 Syntimmune appoints Boehringer, Pfizer alum David de Graaf as CEO, while Gilead promotes James Meyers, IDEXX Laboratories bids farewell to EVP Michael Williams and Biogen recruits two execs for to-be-launched hemophilia spinoff Bioverativ. Plus more hirings, firings and retirings throughout the industry. | | | BioSpecifics Technologies has posted a set of positive data from from its midstage test in patients with cellulite. Statement Novocure says that taking the long-term data from its pivotal study in newly diagnosed brain cancer patients confirms its superior survival rates. Release The WHO has sanctioned a pilot program in sub-Saharan Africa to begin gathering field data on GSK's malaria vaccine from 2018. Story | |
|
Resources Presented By: Lenovo Get the stats you need to start down the path to a more secure infrastructure, today. Presented By: Lenovo What's the first step to a better patient experience? The patient experience starts well before the exam room or even reception - it begins as soon as your patients pull into the parking structure. Presented by: DocuSign DocuSign’s eSignature solutions modernize healthcare and life science organizations by eliminating paper and antiquated signature processes while meeting compliance requirements and reducing costs and errors. Presented by: DocuSign The patients who rely on your scientific leadership are expecting more. Presented by: DocuSign The U.S. Department of Justice has collected upwards of $17 billion in settlements from the healthcare industry since 2009, including more than $2 billion from a single life sciences company. Sponsored By: Salesforce Life sciences companies, like many industries today, face new challenges across the board. Read More. Presented By: ISR Reports Make essential outsourced bioprocessing decisions by staying informed of industry outsourcing practices and contract manufacturer usage patterns with ISR’s Bioprocessing Services and Technologies Market Trends and Outsourcing Dynamics report. Presented By: ISR Reports ISR’s Biosimilars in the US Oncology Market (2nd Edition) report provides data and insights from 101 US-based, board-certified oncologists/hematologist oncologists as to their expectations, fears, and aspirations for biosimilars in oncology. Presented By: ISR Reports Pinpoint the information oncologists find most valuable and the best sales channels for delivering specific types of data/information. Presented By: ISR Reports ISR’s Bioprocessing Market Trends and Outsourcing Dynamics: 2016-2021 report provides an overview of the current market dynamics for bioprocessing as well as an outlook on what the marketplace will look like in five years. Presented By: ISR Reports ISR’s CRO Quality Benchmarking – Phase II/III Service Providers (8th Edition) report provides a Consumer Reports-style analysis of Phase II/III CRO service quality from hundreds of users who rated 44 Phase II/III CROs across 26 critical dimensions of quality. Presented by: Patheon Can you avoid a risky trial-and-error approach to find the right path for your poorly soluble molecule by utilizing a CDMO? Download this complimentary Whitepaper to learn more! Presented by: Biotech Primer This 3-part webinar series is specifically geared toward the non-science professional who needs to better understand industry terminology, science, techniques and issues. Sponsored by: Veeva Systems Gartner research on short- and long-term strategies for IDMP compliance. Fierce Innovation Awards: Life Sciences Edition 2016 Application Deadline: Friday, December 2nd Discover the Richness of Latin America November 29–30, 2016 | San Juan, Puerto Rico Immunotherapy: Mapping the Future of Cancer Drug Discovery November 28, 2016 | Munich, Germany 24th International Molecular Medicine Tri-Conference February 19-24, 2017 | Moscone North Convention Center | San Francisco, CA FierceBiotech Executive Breakfast: Deciphering Immuno-Oncology, Trends in Deal-Making and R&D January 10, 2017 | San Francisco, CA Drug Development Boot CampTM 2016 November 16-17, 2016 | Boston, MA | 